Phase II Trial of Mytomycin C plus Vindesine plus Cisplatin (MVC regimen) for Advanced Non-Small Cell Lung Cancer. Is "Non-Small Cell Lung Cancer" Homogeneous? | Zendy

AI Assistant Blog Pricing

Phase II Trial of Mytomycin C plus Vindesine plus Cisplatin (MVC regimen) for Advanced Non-Small Cell Lung Cancer. Is "Non-Small Cell Lung Cancer" Homogeneous?

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.